Trial suggests Wegovy cuts risk of cardiovascular event in overweight people with heart disease by a fifth.

Source

Only those aged 65 and over or in at-risk groups should be invited for jab, say UK experts.

Source

Clinical trials showed the drug helped to reduce depressive symptoms in as little as three days.

Source